Difference between revisions of "Post-stroke depression"
(Created page with "'''Treatment''' * Antidepressants appear to be helpful in post-stroke depression, in addition to mood benefit, early treatment of post-stroke depression enhances physical and...") |
|||
| Line 3: | Line 3: | ||
* Antidepressants appear to be helpful in post-stroke depression, in addition to mood benefit, early treatment of post-stroke depression enhances physical and cognitive recovery as well (Robinson and Jorge, 2016) | * Antidepressants appear to be helpful in post-stroke depression, in addition to mood benefit, early treatment of post-stroke depression enhances physical and cognitive recovery as well (Robinson and Jorge, 2016) | ||
* The most consistent risk factor for post-stroke depression is severity of impairment in ADLs. Other risk factors include cognitive impairment and history of depression (Robinson and Jorge, 2016) | * The most consistent risk factor for post-stroke depression is severity of impairment in ADLs. Other risk factors include cognitive impairment and history of depression (Robinson and Jorge, 2016) | ||
| − | * Traditionally, left frontal lesions are associated with depression, though a large scale meta-analysis | + | * Traditionally, left frontal lesions are associated with depression, though a large scale meta-analysis could not replicate such an association (Wei et al, 2015) |
* Treatments with nortriptyline 50-100mg QD, citalopram 10-20mg QD, fluoxetine 20mg QD have proven to significantly reduce symptoms of post-stroke depression (Robinson and Jorge, 2016) | * Treatments with nortriptyline 50-100mg QD, citalopram 10-20mg QD, fluoxetine 20mg QD have proven to significantly reduce symptoms of post-stroke depression (Robinson and Jorge, 2016) | ||
Latest revision as of 21:36, 12 June 2021
Treatment
- Antidepressants appear to be helpful in post-stroke depression, in addition to mood benefit, early treatment of post-stroke depression enhances physical and cognitive recovery as well (Robinson and Jorge, 2016)
- The most consistent risk factor for post-stroke depression is severity of impairment in ADLs. Other risk factors include cognitive impairment and history of depression (Robinson and Jorge, 2016)
- Traditionally, left frontal lesions are associated with depression, though a large scale meta-analysis could not replicate such an association (Wei et al, 2015)
- Treatments with nortriptyline 50-100mg QD, citalopram 10-20mg QD, fluoxetine 20mg QD have proven to significantly reduce symptoms of post-stroke depression (Robinson and Jorge, 2016)
References
Robinson, R. G. & Jorge, R. E. Post-Stroke Depression: A Review. Am. J. Psychiatry 173, 221–231 (2016). https://pubmed.ncbi.nlm.nih.gov/26684921/
Wei, N. et al. Post-stroke depression and lesion location: a systematic review. J. Neurol. 262, 81–90 (2015). https://pubmed.ncbi.nlm.nih.gov/25308633/
